Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Welcome, Guest.

Go to Main Navigation

Discovery & Innovation

Showing 41 - 50 of 117 posts
Jul 7, 2014

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...

Jun 30, 2014

Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major therapeutic areas targeted by drug...

Jun 23, 2014

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug...

Jun 18, 2014

Outsourcing has proven to reduce costs while dramatically improving productivity of the drug discovery process. Primary benefits to outsourcing...

Jun 16, 2014

Having introduced the age of the microbiome in drug discovery and the microbiome in metabolic disease we now turn to the influence of the...

Jun 5, 2014

A fluorescent tag, also known as a label or probe, is a molecule that is chemically attached to a biomolecule such as a protein, antibody, or...

May 27, 2014

The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts...

May 22, 2014

How difficult can antibiotic drug discovery be? Some of those struggling with their drug discovery projects in other areas might find themselves...

May 20, 2014

We previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have been...

May 13, 2014

With the increasing need for effective drug development for chronic diseases, collaborations and partnerships between private and public sectors...